Brief summary of the agreement
Anyone is free:
· to copy, distribute, and display the work;
· to make derivative works;
· to make commercial use of the work;
Under the following conditions: Attribution
· the original author must be given credit;
· for any reuse or distribution, it must be made clear to others what the license terms of this work are;
· any of these conditions can be waived if the authors gives permission.
Statutory fair use and other rights are in no way affected by the above
Author Biographies
Gabriel Olabiyi Ogun
Department of Pathology, College of Medicine, University of Ibadan, and University College Hospital, Ibadan, Nigeria
Amos Olufemi Adeleye
Division of Neurological Surgery, Department of Surgery, College of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria
Taiwo Olabimpe Babatunde
Department of Pathology, College of Medicine, University of Ibadan, and University College Hospital, Ibadan, Nigeria
Olufunmilola Abimbola Ogun
Neuro-Ophthalmology Unit, Department of Ophthalmology, College of Medicine, University of Ibadan, and University College Hospital, Ibadan, Nigeria
Ayodeji Salami
Department of Pathology, College of Medicine, University of Ibadan, and University College Hospital, Ibadan, Nigeria
Biobele Jotham Brown
Oncology Unit, Department of Paediatrics, College of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria
Effiong Akang
Department of Pathology, College of Medicine, University of Ibadan, and University College Hospital, Ibadan, Nigeria
Main Article Content
Central nervous system tumours in children in Ibadan, Nigeria: a histopathologic study
Gabriel Olabiyi Ogun
Amos Olufemi Adeleye
Taiwo Olabimpe Babatunde
Olufunmilola Abimbola Ogun
Ayodeji Salami
Biobele Jotham Brown
Effiong Akang
Abstract
Introduction: Contrary to some earlier teachings that central nervous system (CNS) tumours are uncommon in black children, these neoplasms are the fourth most common paediatric tumours in Ibadan. Our centre is the major referral centre for CNS tumours in Nigeria. The last major study of paediatric CNS neoplasms from Ibadan was in 1985. An update of the data on paediatric CNS neoplasms at our centre is presented. Methods: A retrospective review of all histologically diagnosed CNS tumours in children (0-14 years) from January 2001 to December 2010 from the database of the Department of Pathology, University College Hospital, Ibadan, Nigeria was done. The cases were classified using the 2007 WHO Classification of Tumours of the Central Nervous System and were also based on their supratentorial and infratentorial locations. Results: Seventy-seven tumours, 44 in males, were included in the study. Astrocytic tumour comprised 20 cases, embryonal tumours 15, ependymal tumours 15, germ cell tumours 6, sellar tumours (all craniopharyngiomas) 9 and other histological types- 12 cases. Thirty-seven were WHO Grade 1, eleven Grade 2, ten Grade 3 and nineteen Grade 4 neoplasms. Thirty-six cases were supratentorial and thirty-eight were infratentorial in location. The most common tumours in this series were pilocytic astrocytomas, medulloblastomas, craniopharyngiomas and ependymomas in that order. Conclusion: Childhood CNS tumours are being increasingly diagnosed in our centre. This is largely explained by the recent expansion of the available neurosurgical services.
Pan African Medical Journal 2016; 24
Donate
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.